Is Qelbree (viloxazine) indicated for treating mood disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Qelbree is NOT indicated for mood disorders

Qelbree (viloxazine extended-release) is FDA-approved exclusively for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older—it is not indicated for depression or any other mood disorder. 1

FDA-Approved Indication

The FDA label is unequivocal: Qelbree is a selective norepinephrine reuptake inhibitor indicated solely for ADHD treatment 1. While viloxazine in its immediate-release formulation was historically used as an antidepressant in Europe from 1974-2004 2, the extended-release formulation (Qelbree) has been specifically developed and approved only for ADHD, not mood disorders.

Critical Safety Consideration

Qelbree carries a black box warning for suicidal thoughts and behaviors, with clinical studies showing higher rates of suicidal ideation in ADHD patients treated with Qelbree compared to placebo 1. This necessitates:

  • Screening for personal or family history of suicide, bipolar disorder, and depression before initiating treatment
  • Close monitoring for clinical worsening and emergence of suicidal thoughts
  • Regular assessment beginning within 1-2 weeks of initiation

Historical Context vs. Current Use

While older research documents viloxazine's antidepressant effects in immediate-release form 3, 4, this is not applicable to current clinical practice with Qelbree. The extended-release formulation has undergone separate clinical development focused exclusively on ADHD, with different pharmacokinetics and dosing strategies.

If Depression Co-exists with ADHD

For patients with comorbid ADHD and depression, evidence-based treatment for depression should follow established guidelines recommending second-generation antidepressants (SSRIs, SNRIs) or cognitive behavioral therapy 5, 6—not Qelbree. The presence of depression requires screening before starting Qelbree due to the suicidality risk, and may necessitate separate antidepressant treatment.

Do not prescribe Qelbree for mood disorders—use it only for its FDA-approved ADHD indication.

References

4
Research

Alcoholism and depression: a placebo controlled study with viloxazine.

International journal of clinical pharmacology research, 1990

Related Questions

Are there any substances or medications that should be avoided while taking Qelbree (viloxazine), such as caffeine?
Can serdexmethylphenidate/dexmethylphenidate (AZSTARYS) be combined with viloxazine (Qelbree) to improve efficacy?
Can viloxazine extended‑release (Qelbree, generic viloxazine) be combined with other psychiatric medications to treat both attention‑deficit/hyperactivity disorder and generalized anxiety disorder or major depressive disorder?
What are the most common adverse effects of viloxazine?
How should Qelbree (viloxazine) be initiated and managed in patients with motor or vocal tics, including dosing, monitoring, and discontinuation criteria?
During endoscopic laminectomy for spine decompression, what is the recommended irrigation and intravascular fluid management to prevent hyperchloremic metabolic acidosis and renal complications?
What are the types of osteoma and their CT appearance/densities, and where are they most commonly located in the craniofacial region, especially at the osteochondral junction?
Should the duration of surgery and the volume of normal saline (0.9% NaCl) be limited?
What screening is indicated for a 14-year-old male with coarse, broad facial features and a prominent forehead?
What are the recommended volume limits and monitoring parameters when using normal saline (0.9% NaCl) as intra‑operative irrigation fluid?
What is alpha‑gal (galactose‑α‑1,3‑galactose)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.